In vitro antimicrobial activity of nitrofurantoin against Escherichia coli and Staphylococcus pseudintermedius isolated from dogs and cats

Veterinary Microbiology

Volumn 151, Issue 3-4, 2011, Pages 396-399

  Maaland, Marit ^a   Guardabassi, Luca ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Antibiotic resistance; Cystitis; Rational antibiotic use; Veterinary medicine

Indexed keywords

NITROFURANTOIN;

ANIMAL EXPERIMENT; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CAT; CONTROLLED STUDY; DOG; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION; STAPHYLOCOCCUS PSEUDINTERMEDIUS; URINARY TRACT INFECTION;

ANIMALS; ANTI-INFECTIVE AGENTS; CAT DISEASES; CATS; DOG DISEASES; DOGS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; MICROBIAL SENSITIVITY TESTS; NITROFURANTOIN; STAPHYLOCOCCUS; URINARY TRACT INFECTIONS;

ANIMALIA; BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; ESCHERICHIA COLI; FELIDAE; STAPHYLOCOCCUS PSEUDINTERMEDIUS;

EID: 79960192095     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2011.03.009     Document Type: Article

References (28)

1. Ball K.R., Rubin J.E., Chirino-Trejo M., Dowling P.M. Antimicrobial resistance and prevalence of canine uropathogens at the Western College of Veterinary Medicine Veterinary Teaching Hospital, 2002-2007. Can. Vet. J. 2008, 49:985-990.
2. Blondeau J.M. New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach. Vet. Dermatol. 2009, 20:383-396.
3. Boothe D.M. Principles of antimicrobial therapy. Vet. Clin. North Am. Small Anim. Pract. 2006, 36:1003-1047.
4. Breeze A.S., Obaseiki-Ebor E.E. Mutations to nitrofurantoin and nitrofurazone resistance in Escherichia coli K12. J. Gen. Microbiol. 1983, 129:99-103.
5. Carattoli A., Lovari S., Franco A., Cordaro G., Di Matteo P., Battisti A. Extended-spectrum beta-lactamases in Escherichia coli isolated from dogs and cats in Rome, Italy, from 2001 to 2003. Antimicrob. Agents Chemother. 2005, 49:833-835.
6. Clinical and Laboratory Standards Institute (CLSI). 2008. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals. Approved Standard - Third Edition M31-A3. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Clinical and Laboratory Standards Institute (CLSI). 2010. Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement. Approved Standard M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Conklin J.D., Sobers R.J., Wagner D.L. Urinary drug excretion in dogs during therapeutic doses of different nitrofurantoin dosage forms. J. Pharm. Sci. 1969, 58:1365-1368.
9. El Zubeir I.E.M., Kanbar T., Alber J., Lammler C., Akineden O., Weiss R., Zschock M. Phenotypic and genotypic characteristics of methicillin/oxacillin-resistant Staphylococcus intermedius isolated from clinical specimens during routine veterinary microbiological examinations. Vet. Microbiol. 2007, 121:170-176.
10. Garau J. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline. Clin. Microbiol. Infect. 2008, 14:198-202.
11. Hansen G.T., Blondeau J.M. Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens. J. Chemother. 2005, 17:484-492.
12. Hooper D.C. Urinary tract agents: nitrofurantoin and methenamine. Principles and Practice of Infectious Diseases 2010, Elsevier, Philadelphia. G.L. Mandell, J.E. Bennet, R. Dolin (Eds.).
13. Kadlec K., Schwarz S., Perreten V., Andersson U.G., Finn M., Greko C., Moodley A., Kania S.A., Frank L.A., Bemis D.A., Franco A., Iurescia M., Battisti A., Duim B., Wagenaar J.A., van Duijkeren E., Weese J.S., Fitzgerald J.R., Rossano A., Guardabassi L. Molecular analysis of methicillin-resistant Staphylococcus pseudintermedius of feline origin from different European countries and North America. J. Antimicrob. Chemother. 2010, 65:1826-1828.
14. Kashanian J., Hakimian P., Blute M., Wong J., Khanna H., Wise G., Shabsigh R. Nitrofurantoin: the return of an old friend in the wake of growing resistance. Br. J. Urol. Int. 2008, 102:1634-1637.
15. Ling G.V., Norris C.R., Franti C.E., Eisele P.H., Johnson D.L., Ruby A.L., Jang S.S. Interrelations of organism prevalence, specimen collection method, and host age, sex, and breed among 8354 canine urinary tract infections (1969-1995). J. Vet. Intern. Med. 2001, 15:341-347.
16. Loeffler A., Linek M., Moodley A., Guardabassi L., Sung J.M.L., Winkler M., Weiss R., Lloyd D.H. First report of multiresistant, mecA-positive Staphylococcus intermedius in Europe: 12 cases from a veterinary dermatology referral clinic in Germany. Vet. Dermatol. 2007, 18:412-421.
17. Niazi S., Vishnupad K.S., Vengpedersen P. Absorption and disposition characteristics of nitrofurantoin in dogs. Biopharmaceut. Drug Disp. 1983, 4:213-223.
18. Ogeer-Gyles J., Mathews K., Weese J.S., Prescott J.F., Boerlin P. Evaluation of catheter-associated urinary tract infections and multi-drug-resistant Escherichia coli isolates from the urine of dogs with indwelling urinary catheters. J. Am. Vet. Med. Assoc. 2006, 229:1584-1590.
19. Perreten V., Kadlec K., Schwarz S., Andersson U.G., Finn M., Greko C., Moodley A., Kania S.A., Frank L.A., Bemis D.A., Franco A., Iurescia M., Battisti A., Duim B., Wagenaar J.A., van Duijkeren E., Weese J.S., Fitzgerald J.R., Rossano A., Guardabassi L. Clonal spread of methicillin-resistant Staphylococcus pseudintermedius in Europe and North America: an international multicentre study. J. Antimicrob. Chemother. 2010, 65:1145-1154.
20. Pomba C., Couto N., Moodley A. Treatment of a lower urinary tract infection in a cat caused by a multi-drug methicillin-resistant Staphylococcus pseudintermedius and Enterococcus faecalis. J. Fel. Med. Surg. 2010, 12:802-806.
21. Rohrich P.J., Ling G.V., Ruby A.L., Jang S.S., Johnson D.L. In vitro susceptibilities of canine urinary bacteria to selected antimicrobial agents. J. Am. Vet. Med. Assoc. 1983, 183:863-867.
22. Ruscher C., Lubke-Becker A., Wleklinski C.G., Soba A., Wieler L.H., Walther B. Prevalence of Methicillin-resistant Staphylococcus pseudintermedius isolated from clinical samples of companion animals and equidaes. Vet. Microbiol. 2009, 136:197-201.
23. Sanchez S., Stevenson M.A.M., Hudson C.R., Maier M., Buffington T., Dam Q., Maurer J.J. Characterization of multidrug-resistant Escherichia coli isolates associated with nosocomial infections in dogs. J. Clin. Microbiol. 2002, 40:3586-3595.
24. Sandegren L., Lindqvist A., Kahlmeter G., Andersson D.I. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli. J. Antimicrob. Chemother. 2008, 62:495-503.
25. Schito G.C., Naber K.G., Botto H., Palou J., Mazzei T., Gualco L., Marchese A. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int. J. Antimicrob. Agents 2009, 34:407-413.
26. Shaheen B.W., Boothe D.M., Oyarzabal O.A., Smaha T. Antimicrobial resistance profiles and clonal relatedness of canine and feline Escherichia coli pathogens expressing multidrug resistance in the United States. J. Vet. Intern. Med. 2010, 24:323-330.
27. Warren A.L., Townsend K.M., King T., Moss S., O'Boyle D., Yates R.M., Trott D.J. Multi-drug resistant Escherichia coli with extended-spectrum beta-lactamase activity and fluoroquinolone resistance isolated from clinical infections in dogs. Aust. Vet. J. 2001, 79:621-623.
28. Zhanel G.G., Hisanaga T.L., Laing N.M., DeCorby M.R., Nichol K.A., Palatnick L.P., Johnson J., Noreddin A., Harding G.K.M., Nicolle L.E., Hoban D.J. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int. J. Antimicrob. Agents 2005, 26:380-388.